Real-World Evidence Needs for Treatment Sequence Disease Modelling in Refractory Inflammatory Bowel Disease

被引：0
|
作者：
Kodjamanova, P. [1 ]
Sanon, M. [2 ]
Dimova, M. [3 ]
Wu, E. [2 ]
Atanasov, P. [4 ]
机构：
[1] Amaris Consulting, Real World Evidence, London, England
[2] Janssen Global Serv, Global Market Access, Raritan, NJ USA
[3] Janssen Global Serv, HTA Modelling, Horsham, PA USA
[4] Amaris Consulting, Real World Evidence, Barcelona, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1437
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1263
引用
收藏
页码：i2288 / i2288
页数：1
相关论文
共 50 条
  • [21] Real-World Outcomes of Dual Advanced Therapy in Inflammatory Bowel Disease
    Kellar, Amelia
    Dolinger, Michael
    Spencer, Elizabeth
    Dubinsky, Marla C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S4 - S4
  • [22] Effectiveness and Safety Analysis of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
    Wu, H.
    Su, T.
    Wu, L.
    Zhi, M.
    Yao, J.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1216 - i1217
  • [23] An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
    Wu, Hongzhen
    Xie, Tingting
    Yu, Qiao
    Su, Tao
    Zhang, Min
    Wu, Luying
    Wang, Xiaoling
    Peng, Xiang
    Zhi, Min
    Yao, Jiayin
    BIOMEDICINES, 2025, 13 (01)
  • [24]  Escalated Ustekinumab dosing in inflammatory bowel disease - efficacy and safety profiles of real-world treatment
    Chandwe, Kanta
    Bwakura-Dangarembizi, Mutsa
    Amadi, Beatrice
    Tawodzera, Gertrude
    Murch, Simon
    Hill, Susan
    Playford, Ray
    VanBuskirk, Kelley
    Prendergast, Andrew
    Kelly, Paul
    GUT, 2023, 72 (SUPPL_2) : A121 - A121
  • [25] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [26] Prospective outcome following ustekinumab treatment in a real-world cohort of inflammatory bowel disease patients
    Lopez, L. Ramos
    Ramos-Diaz, R.
    Benitez-Zafra, F.
    Morant-Dominguez, A.
    Vera-Santana, B.
    Mourani-Padron, I.
    Alonso-Abreu, I.
    Carrillo-Palau, M.
    Reygosa, C.
    Medina-Chico, J. S.
    Gutierrez-Nicolas, F.
    Nazco-Casariego, J.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1587 - I1588
  • [27] Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in US Adults
    Wang, Tiansheng
    Yang, Jeff Y.
    Buse, John B.
    Pate, Virginia
    Tang, Huilin
    Barnes, Edward L.
    Sandler, Robert S.
    Sturmer, Til
    DIABETES CARE, 2019, 42 (11) : 2065 - 2074
  • [28] SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE ON ADHERENCE WITH BIOLOGICS IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
    Rupniewska, E.
    Singer, D.
    Khan, S.
    Neighbors, M.
    Chiarappa, J. A.
    Obando, C. A.
    VALUE IN HEALTH, 2018, 21 : S87 - S87
  • [29] Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
    Cyrla Zaltman
    Rogério Serafim Parra
    Ligia Yukie Sassaki
    Genoile Oliveira Santana
    Maria de Lourdes Abreu Ferrari
    Sender J Miszputen
    Heda M B S Amarante
    Roberto Luiz Kaiser Junior
    Cristina Flores
    Wilson R Catapani
    José Miguel Luz Parente
    Mauro Bafutto
    Odery Ramos
    Carolina D Gon?alves
    Isabella Miranda Guimaraes
    Jose J R da Rocha
    Marley R Feitosa
    Omar Feres
    Rogerio Saad-Hossne
    Francisco Guilherme Cancela Penna
    Pedro Ferrari Sales Cunha
    Tarcia NF Gomes
    Rodrigo Bremer Nones
    Mikaell Alexandre Gouvea Faria
    Mírian Perpétua Palha Dias Parente
    António S Scotton
    Rosana Fusaro Caratin
    Juliana Senra
    Júlio Maria Chebli
    World Journal of Gastroenterology, 2021, 27 (02) : 208 - 223
  • [30] Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
    Zaltman, Cyrla
    Parra, Rogerio Serafim
    Sassaki, Ligia Yukie
    Santana, Genoile Oliveira
    Ferrari, Maria de Lourdes Abreu
    Miszputen, Sender J.
    Amarante, Heda M. B. S.
    Kaiser Junior, Roberto Luiz
    Flores, Cristina
    Catapani, Wilson R.
    Parente, Jose Miguel Luz
    Bafutto, Mauro
    Ramos, Odery
    Goncalves, Carolina D.
    Guimaraes, Isabella Miranda
    da Rocha, Jose J. R.
    Feitosa, Marley R.
    Feres, Omar
    Saad-Hossne, Rogerio
    Penna, Francisco Guilherme Cancela
    Cunha, Pedro Ferrari Sales
    Gomes, Tarcia N. F.
    Nones, Rodrigo Bremer
    Faria, Mikaell Alexandre Gouvea
    Parente, Mirian Perpetua Palha Dias
    Scotton, Antonio S.
    Caratin, Rosana Fusaro
    Senra, Juliana
    Chebli, Julio Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (02) : 208 - 223
12345